City

Bethesda (1)

Dallas (1)

Florence (1)

Fort Worth (1)

Houston (1)

Oklahoma City (1)

San Antonio (1)

Overall Status

Completed (1)

Recruiting (1)

Terminated (1)

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Baylor College of Medicine (1)

Chimerix (1)

Meyer Children's Hospital (1)

Collaborator

Cook Children's Medical Center (1)

M.D. Anderson Cancer Center (1)

National Institutes of Health (NIH) (1)

The University of Texas Health Science Center at San Antonio (1)

University of Oklahoma (1)

University of Texas, Southwestern Medical Center at Dallas (1)

Intervention

bevacizumab (1)

doxorubicin (1)

onc206 (1)

radiation therapy (1)

valproic acid (1)

Study Documents

Intervention Type

drug (3)

radiation (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

gliomatosis cerebri

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

Recruiting

Central Nervous System Neoplasms
+22 more

ONC206

Bethesda, Maryland

National Institutes of Health

Mar 1, 2022

Glial Cell Tumors, Malignant Gliomas, Glioblastoma Multiforme Trial in United States (Valproic acid, Bevacizumab, Radiation

Completed

Has Results

Glial Cell Tumors
+7 more

Valproic acid
+2 more

Oklahoma City, Oklahoma
+5 more

Jun 30, 2021

Glioblastoma (GBM), DIPG, Brainstem Glioma, Pediatric Trial in Florence (Doxorubicin)

Terminated

Glioblastoma (GBM)
+7 more

Doxorubicin

Florence, Italy

Meyer Children's Hospital

Feb 4, 2021